CGEM EPS Estimates
Cullinan Therapeutics, Inc.
$13.64
-$0.46(-3.26%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$877.80M
Volume
903.10K
52W Range
$6.73 - $23.19
Target Price
$35.64
CGEM EPS estimates: the consensus estimate for Cullinan Therapeutics, Inc.'s current fiscal year is -$3.06 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CGEM EPS Estimates
- EPS estimate, current quarter
- $-0.79
- EPS estimate, next quarter
- $-0.71
- EPS estimate, current year
- $-3.06
- EPS estimate, next year
- $-2.43
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.36 |
| 2023 | $-3.69 |
| 2022 | $2.46 |
| 2021 | $-1.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEM | $13.64 | -3.3% | 903.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cullinan Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW